Connectus Wealth’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-24,100
Closed -$1.39M 388
2023
Q4
$1.39M Buy
24,100
+313
+1% +$16.7K 0.03% 299
2023
Q3
$1.26M Buy
23,787
+28
+0.1% +$1.47K 0.03% 296
2023
Q2
$1.29M Buy
23,759
+22
+0.1% +$1.15K 0.03% 262
2023
Q1
$1.19M Sell
23,737
-3,373
-12% -$159K 0.03% 271
2022
Q4
$1.25M Sell
27,110
-97
-0.4% -$4.2K 0.03% 264
2022
Q3
$1.05M Sell
27,207
-153
-0.6% -$6.14K 0.02% 330
2022
Q2
$1.02M Sell
27,360
-333
-1% -$13.6K 0.02% 271
2022
Q1
$1.18M Sell
27,693
-31
-0.1% -$1.34K 0.04% 222
2021
Q4
$1.18M Buy
+27,724
New +$1.16M 0.05% 205

Other funds holding BSX

Connectus Wealth's BSX Position: Q1 2024 in Review

Connectus Wealth sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 24,100 shares — an estimated $1.39M sold.

Connectus Wealth first reported a position in BSX in Q4 2021 and held it in 9 quarters. The position peaked at $1.39M in Q4 2023. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Connectus Wealth reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • Connectus Wealth sold 24,100 Boston Scientific shares in Q1 2024, an estimated $1.39M.
  • Connectus Wealth first reported a position in Boston Scientific in Q4 2021 and held it in 9 quarters.
  • Connectus Wealth's Boston Scientific position peaked at $1.39M in Q4 2023.
  • 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.